Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 101 to 150 of 1861
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis
IPG110
23 February 2005
23 February 2005
Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis
IPG111
23 February 2005
23 February 2005
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitors
TA813
3 August 2022
3 August 2022
Asfotase alfa for treating paediatric-onset hypophosphatasia
HST23
1 March 2023
1 March 2023
Assessing motility of the gastrointestinal tract using a wireless capsule
IPG502
23 August 2014
23 August 2014
Asthma: diagnosis, monitoring and chronic asthma management
NG80
29 November 2017
22 March 2021
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene
HST22
22 February 2023
22 February 2023
Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer
TA823
28 September 2022
28 September 2022
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy
TA520
16 May 2018
16 May 2018
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
TA525
13 June 2018
13 June 2018
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable
TA739
27 October 2021
27 October 2021
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer
TA584
5 June 2019
5 June 2019
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer
TA705
2 June 2021
2 June 2021
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma
TA666
16 December 2020
16 December 2020
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer
TA638
1 July 2020
1 July 2020
Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal)
TA618
15 January 2020
15 January 2020
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer
TA639
1 July 2020
1 July 2020
Atidarsagene autotemcel for treating metachromatic leukodystrophy
HST18
28 March 2022
28 March 2022
Atogepant for preventing migraine
TA973
15 May 2024
15 May 2024
Atopic eczema in under 12s: diagnosis and management
CG57
12 December 2007
7 June 2023
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system)
DG14
24 September 2014
19 December 2017
Atrial fibrillation: diagnosis and management
NG196
27 April 2021
30 June 2021
Attention deficit hyperactivity disorder: diagnosis and management
NG87
14 March 2018
13 September 2019
Auditory brain stem implants
IPG108
26 January 2005
26 January 2005
Autism spectrum disorder in adults: diagnosis and management
CG142
27 June 2012
14 June 2021
Autism spectrum disorder in under 19s: recognition, referral and diagnosis
CG128
28 September 2011
20 December 2017
Autism spectrum disorder in under 19s: support and management
CG170
28 August 2013
14 June 2021
Autologous blood injection for plantar fasciitis
IPG437
23 January 2013
23 January 2013
Autologous blood injection for tendinopathy
IPG438
23 January 2013
23 January 2013
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee
TA477
4 October 2017
4 October 2017
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee
TA508
7 March 2018
7 March 2018
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy
IPG274
24 September 2008
24 September 2008
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers
DG52
24 May 2023
24 May 2023
Automated percutaneous mechanical lumbar discectomy
IPG141
23 November 2005
23 November 2005
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis
TA825
21 September 2022
21 September 2022
Avalglucosidase alfa for treating Pompe disease
TA821
24 August 2022
24 August 2022
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)
TA730
29 September 2021
29 September 2021
Avatrombopag for treating primary chronic immune thrombocytopenia
TA853
15 December 2022
15 December 2022
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
TA626
24 June 2020
24 June 2020
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy
TA788
11 May 2022
11 May 2022
Avelumab for treating metastatic Merkel cell carcinoma
TA517
11 April 2018
21 April 2021
Avelumab for untreated metastatic Merkel cell carcinoma
TA691
21 April 2021
21 April 2021
Avelumab with axitinib for untreated advanced renal cell carcinoma
TA645
2 September 2020
2 September 2020
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies
TA872
28 February 2023
28 February 2023
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy
TA895
7 June 2023
7 June 2023
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma
TA894
7 June 2023
7 June 2023
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment
TA333
25 February 2015
25 February 2015
Axonics sacral neuromodulation system for treating refractory overactive bladder
MTG50
3 September 2020
3 September 2020
Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia
TA218
23 March 2011
23 March 2011
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts
TA399
27 July 2016
27 July 2016
Previous page
1
2
Current page
3
4
5
…
38
Page
3
of
38
Next page
Results per page
10
25
50
All
Back to top